Radiopharm Theranostics Ltd (RADX)

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.74
Day's range
$4.98

Radiopharm Theranostics Ltd Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2026 51.00 M $738.98 K   0.00% 735.20%
SILVERARC CAPITAL MANAGEMENT, LLC 05/14/2026 187.41 K $805.85 K   0.00% 2.70%
HSBC HOLDINGS PLC 04/30/2026 61.37 K $264.51 K   -67.97% 0.88%
REGAL PARTNERS LTD 05/15/2026 40.14 K $172.59 K   -55.85% 0.58%
PNC FINANCIAL SERVICES GROUP, INC. 05/08/2026 16.00 K $68.80 K   0.00% 0.23%
UBS GROUP AG 05/05/2026 3.00 K $12.90 K   -78.99% 0.04%
RHUMBLINE ADVISERS 05/12/2026 121 $519   1,916.67% 0.00%
VIRTU FINANCIAL LLC 05/14/2026 0 $0   -100.00% 0.00%
JANE STREET GROUP, LLC 05/12/2026 0 $0   -100.00% 0.00%
STRATEGIC WEALTH PARTNERS, LTD. 05/12/2026 0 $0   -100.00% 0.00%
MAREX GROUP PLC 05/13/2026 0 $0   -100.00% 0.00%

Radiopharm Theranostics Ltd institutional Ownership - FAQ's

During the previous two years, 11 institutional investors and hedge funds held shares of Radiopharm Theranostics Ltd. The most heavily invested institutionals were:

Stonepine Capital Management, LLC: 51 M

SILVERARC CAPITAL MANAGEMENT, LLC: 187,406

HSBC HOLDINGS PLC: 61,372

Regal Partners Ltd: 40,138

PNC FINANCIAL SERVICES GROUP, INC.: 16,000

UBS Group AG: 3,000

739.64% of Radiopharm Theranostics Ltd stock is owned by institutional investors.

Institutional investors have bought a total of 51.31 M shares in the last 24 months. This purchase volume represents approximately $253.46 M in transactions.